Breast Cancer News and Research

Latest Breast Cancer News and Research

Merrimack begins MM-121 Phase 2 combination trial in HER2-negative breast cancer

Merrimack Pharmaceuticals, Inc. announced today that the first patient has been dosed in a randomized Phase 2 clinical trial of MM-121, a fully human monoclonal antibody that targets ErbB3, combined with paclitaxel in the neoadjuvant setting of HER2-negative breast cancer patients.

12 Oct 2011

DMC completes review of BioSante's LibiGel Phase III cardiovascular and breast cancer study

BioSante Pharmaceuticals, Inc., announced today that the independent Data Monitoring Committee (DMC) has completed the seventh unblinded review of the LibiGel Phase III cardiovascular and breast cancer safety study, which has completed enrollment of subjects.

11 Oct 2011

AIM at Melanoma applauds bill banning children from using indoor tanning beds

AIM at Melanoma, the largest international foundation dedicated to melanoma research and patient advocacy, applauds Governor Jerry Brown's signing today of Senate Bill 746, which now bans children under 18 from using indoor tanning beds. Tanning beds have been linked to the rapid rise in melanoma rates among 15-39 year olds.

10 Oct 2011

Beauty Encounter sponsors ACS's premier breast cancer event

Beauty Encounter, a premier online source for all things fragrance and beauty and specializing in hard-to-find niche products, sponsored the American Cancer Society's annual Making Strides Against Breast Cancer walk in the local Orange County event that took place on October 9, 2011 at the Segerstrom Center in Costa Mesa.

10 Oct 2011

Osteoporosis drug protects against bone damaging side effects of breast cancer medications

A new study has found that an osteoporosis drug protects against the bone damaging side effects of certain breast cancer medications. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the study indicates that some breast cancer patients could take zoledronic acid in addition to their anti-cancer medications to maintain bone health.

10 Oct 2011

MicroRNA-101 can block autophagy in cancer cells

All cells in our body have a system that can handle cellular waste and release building blocks for recycling. The underlying mechanism is called autophagy and literally means "self-eating". Many cancer cells have increased the activity of this system and the increased release of building blocks equip the cancer cells with a growth advantage and can render them resistant towards treatment.

10 Oct 2011

Boehringer Ingelheim receives FDA approval for COMBIVENT RESPIMAT to treat COPD

Boehringer Ingelheim Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved COMBIVENT RESPIMAT, a new, propellant-free inhaler product that uses a slow-moving mist to deliver the same active ingredients of COMBIVENT Inhalation Aerosol in a metered dose inhaler.

10 Oct 2011

Preventive task force panel will urge men to skip prostate screening, reports say

The U.S. Preventive Services Task Force is scheduled to issue this recommendation on Tuesday, but advance press reports indicate the expert panel will urge the federal government to change its current position to recommend that men under age 75 forgo this widely used test.

7 Oct 2011

First Edition: October 7, 2011

In today's headlines, reports about what the Institute of Medicine recommends in terms of the criteria and methods the Department of Health and Human Services should follow in developing the health law's essential benefits package.

7 Oct 2011

USPTO awards HistoRx two patents for methods of standardization of digital microscopy instruments

HistoRx, the leader in quantitative immunohistochemistry, advances its proprietary position in digital pathology through the recent issuance of US patents covering key features necessary for achievement of reproducible, standardized image analysis results.

7 Oct 2011

Report on cancer survivorship statistics

Over the next decade, the population of cancer survivors over 65 years of age will increase by approximately 42 percent.

7 Oct 2011

Ibris to develop a quick and economical analysis of tissue from breast cancer biopsies

The National Institutes of Health (NIH) has awarded a Rutgers-affiliated company $207,000 to develop a quick and economical analysis of tissue from breast cancer biopsies. The technology is designed to predict how aggressive a common form of breast cancer is likely to be, helping physicians and patients plan effective therapies that minimize side effects.

7 Oct 2011

Loyola participates in Pink Glove Dance competition to raise breast cancer awareness

Not since the likes of Fame, Flashdance or Fred Astaire has the Chicago area seen such dancing talent as is showcased in Loyola University Health System's new Pink Glove Dance video. This video is part of the Pink Glove Dance phenomenon that is sweeping the nation.

7 Oct 2011

Cannabidiol could prevent onset of pain associated with chemotherapy drugs

A chemical component of the marijuana plant could prevent the onset of pain associated with drugs used in chemo therapy, particularly in breast cancer patients, according to researchers at Temple University's School of Pharmacy.

7 Oct 2011

Longer looks: A new life for Bart Stupak; The Komen Foundation and BPA; moving primary care out of the ER

Former Democratic congressman Bart Stupak is relishing the good life. After nine terms in the House of Representatives, the once obscure, pro-life, conservative legislator who became the flash point in last year's historic health care debate gave up his seat to become a gilded Washington operative - a partner in the Government and Legislative Affairs Group of Venable LLP. … Even before he negotiated a last-minute deal with President Obama to ban federal funding for abortion and provided the defining vote, he called his life "a living hell." "I was the face of health care. Whatever you thought about it, I was it," he says calmly. "I'm surprised I never got shot."

7 Oct 2011

JCO publishes data from Celgene's ABRAXANE Phase II combination trial on pancreatic cancer

Celgene International Sàrl today announced that results from a clinical study of ABRAXANE in combination with gemcitabine in 67 patients with previously untreated advanced pancreatic cancer were published in an online article by the Journal of Clinical Oncology ahead of print.

7 Oct 2011

Strain echocardiography can help physicians detect early signs of cardiac toxicity in cancer patients

There is good news for cancer patients whose medical treatments put them at risk for future cardiac problems: using strain echocardiography can help physicians detect early signs of cardiac toxicity.

7 Oct 2011

Herceptin chemo combination could mean longer survival and lower side effects in breast cancer patients: Study

A new study released this Wednesday revealed that breast cancer that is highly aggressive but caught early could be best treated with a combination of Herceptin and chemotherapy.

6 Oct 2011

Pregnant mums taking miscarriage prevention drug decades ago may have put their girls at risk of infertility and cancers

A new study reveals that a drug that was taken by millions of pregnant women decades ago to prevent miscarriage and complications has put their daughters at higher risk for breast cancer and other health problems. The study shows that many of these daughters are now over 40 and may not even know of their risk if their mothers never realized or told them they had used the drug, a synthetic estrogen called DES or Diethyl stilbesterol.

6 Oct 2011

Vitamin D deficiency might be common in fair skinned people: Study

The British study suggests that pale people tend to be deficient in the “sunshine” vitamin and that without supplements they're unlikely to get their levels up without getting sunburned. That can put them at risk for bone loss, heart disease, and poorer survival from breast cancer, according to the study's authors.

5 Oct 2011

Breast Cancer News and Research

Latest Breast Cancer News and Research

Merrimack begins MM-121 Phase 2 combination trial in HER2-negative breast cancer

DMC completes review of BioSante's LibiGel Phase III cardiovascular and breast cancer study

AIM at Melanoma applauds bill banning children from using indoor tanning beds

Beauty Encounter sponsors ACS's premier breast cancer event

Osteoporosis drug protects against bone damaging side effects of breast cancer medications

MicroRNA-101 can block autophagy in cancer cells

Boehringer Ingelheim receives FDA approval for COMBIVENT RESPIMAT to treat COPD

Preventive task force panel will urge men to skip prostate screening, reports say

First Edition: October 7, 2011

USPTO awards HistoRx two patents for methods of standardization of digital microscopy instruments

Report on cancer survivorship statistics

Ibris to develop a quick and economical analysis of tissue from breast cancer biopsies

Loyola participates in Pink Glove Dance competition to raise breast cancer awareness

Cannabidiol could prevent onset of pain associated with chemotherapy drugs

Longer looks: A new life for Bart Stupak; The Komen Foundation and BPA; moving primary care out of the ER

JCO publishes data from Celgene's ABRAXANE Phase II combination trial on pancreatic cancer

Strain echocardiography can help physicians detect early signs of cardiac toxicity in cancer patients

Herceptin chemo combination could mean longer survival and lower side effects in breast cancer patients: Study

Pregnant mums taking miscarriage prevention drug decades ago may have put their girls at risk of infertility and cancers

Vitamin D deficiency might be common in fair skinned people: Study

Industry Focus eBook - Oncology (1st Edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Breast Cancer News and Research

Latest Breast Cancer News and Research

Industry Focus eBook - Oncology (1st Edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in